In the evolving landscape of pharmaceuticals, a new generation of software-enhanced drugs is emerging, combining traditional pharmacotherapy with digital therapeutics to optimize patient outcomes. In this BioSpace article, David Benshoof Klein, Founder & CEO of Click Therapeutics, explains how these "smart" medications integrate personalized digital treatments, allowing for adaptive responses such as tailored side effect management and individualized dose adjustments. As clinical evidence grows, it's anticipated that pharmaceutical pipelines will increasingly feature these digital counterparts, transforming the standard of care. Learn more about how software-enhanced drugs are revolutionizing healthcare in the full article.